HSBC Holdings
BNR

HSBC Holdings’s Burning Rock Biotech BNR Stock Holding History

HSBC Holdings’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,965
Closed -$3.03M – 3258
2021
Q3 		$3.03M Buy
16,965
+4,893
+41% +$1.09M ﹤0.01% 1364
2021
Q2 		$3.56M Sell
12,072
-10,487
-46% -$3.1M ﹤0.01% 1223
2021
Q1 		$6.07M Sell
22,559
-15,382
-41% -$4.68M 0.01% 950
2020
Q4 		$8.76M Sell
37,941
-11,601
-23% -$3.11M 0.01% 826
2020
Q3 		$12.4M Buy
+49,542
New +$11.7M 0.02% 634

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HSBC Holdings's BNR Position: Q4 2021 in Review

HSBC Holdings sold out of Burning Rock Biotech (BNR) in Q4 2021, closing a stake of 16,965 shares — an estimated $3.03M sold.

HSBC Holdings first reported a position in BNR in Q3 2020 and held it in 5 quarters. The position peaked at $12.4M in Q3 2020. 62 funds tracked by Wall St. Rank hold BNR as of Q4 2021.

  • HSBC Holdings reported no remaining Burning Rock Biotech position as of Q4 2021 after selling out during the quarter.
  • HSBC Holdings sold 16,965 Burning Rock Biotech shares in Q4 2021, an estimated $3.03M.
  • HSBC Holdings first reported a position in Burning Rock Biotech in Q3 2020 and held it in 5 quarters.
  • HSBC Holdings's Burning Rock Biotech position peaked at $12.4M in Q3 2020.
  • 62 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2021.

Based on HSBC Holdings's 13F filing for Q4 2021, filed 11 Feb 2022.